Arrow Mark Colorado Holdings LLC C4 Therapeutics, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

  • $4.91 Billion
  • Q2 2025

A detailed history of Arrow Mark Colorado Holdings LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 204,505 shares of CCCC stock, worth $554,208. This represents 0.01% of its overall portfolio holdings.

Number of Shares
204,505
Previous 1,286,712 84.11%
Holding current value
$554,208
Previous $2.06 Million 85.81%
% of portfolio
0.01%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$1.1 - $1.74 $1.19 Million - $1.88 Million
-1,082,207 Reduced 84.11%
204,505 $292,000
Q1 2025

May 15, 2025
SELL
$1.6 - $4.09 $75,822 - $193,821
-47,389 Reduced 3.55%
1,286,712 $2.06 Million
Q4 2024

Feb 14, 2025
BUY
$3.6 - $7.0 $52,621 - $102,319
14,617 Added 1.11%
1,334,101 $4.8 Million
Q3 2024

Nov 14, 2024
BUY
$4.43 - $7.38 $332,808 - $554,429
75,126 Added 6.04%
1,319,484 $7.52 Million
Q2 2024

Aug 14, 2024
SELL
$4.05 - $8.1 $192,703 - $385,406
-47,581 Reduced 3.68%
1,244,358 $5.75 Million
Q1 2024

May 15, 2024
SELL
$5.3 - $11.0 $4.48 Million - $9.3 Million
-845,442 Reduced 39.56%
1,291,939 $10.6 Million
Q4 2023

Feb 14, 2024
BUY
$1.18 - $6.03 $2.16 Million - $11 Million
1,827,626 Added 590.02%
2,137,381 $12.1 Million
Q2 2023

Aug 14, 2023
SELL
$2.75 - $3.77 $16.7 Million - $22.9 Million
-6,071,125 Reduced 95.15%
309,755 $851,000
Q1 2023

May 15, 2023
BUY
$3.1 - $9.02 $1.79 Million - $5.21 Million
578,009 Added 9.96%
6,380,880 $20 Million
Q4 2022

Feb 14, 2023
BUY
$5.42 - $10.24 $3.85 Million - $7.28 Million
710,896 Added 13.96%
5,802,871 $34.2 Million
Q3 2022

Nov 14, 2022
SELL
$8.03 - $12.77 $6.03 Million - $9.58 Million
-750,432 Reduced 12.84%
5,091,975 $44.7 Million
Q2 2022

Aug 15, 2022
BUY
$5.06 - $26.46 $19.9 Million - $104 Million
3,933,384 Added 206.04%
5,842,407 $44.1 Million
Q1 2022

May 16, 2022
BUY
$19.99 - $33.23 $2.69 Million - $4.47 Million
134,519 Added 7.58%
1,909,023 $46.3 Million
Q4 2021

Feb 14, 2022
BUY
$29.39 - $46.86 $7.64 Million - $12.2 Million
259,884 Added 17.16%
1,774,504 $57.1 Million
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $4.27 Million - $6.01 Million
118,999 Added 8.53%
1,514,620 $67.7 Million
Q2 2021

Aug 16, 2021
BUY
$30.39 - $42.18 $34.8 Million - $48.3 Million
1,144,004 Added 454.66%
1,395,621 $52.8 Million
Q1 2021

May 17, 2021
BUY
$31.96 - $46.5 $78,877 - $114,762
2,468 Added 0.99%
251,617 $9.31 Million
Q4 2020

Feb 16, 2021
BUY
$22.8 - $37.05 $5.68 Million - $9.23 Million
249,149 New
249,149 $8.25 Million

Others Institutions Holding CCCC

# of Institutions
105
Shares Held
57.2M
Call Options Held
15.2K
Put Options Held
0
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $133M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email